2016 International Congress

Tuesday, June 21, 2016

12:30pm-2:00pm

Sodium butyrate attenuates rotenone-induced neurodegeneration via enhancing autophagy and preventing α-synuclein aggregation

L. Liu, C. Han, K. Ma, X. Xu, J. Huang, N. Xiong, T. Wang (Wuhan, People's Republic of China)

Parkinson's disease: Pathophysiology  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Sonographic investigation of Pisa syndrome in Parkinson’s disease

J. Shiraishi, T. Okazaki, M. Mizuba, K. Kajiwara, S. Saeki, R. Matsugaki, T. Takei, T. Uozumi (Fukuoka, Japan)

Parkinson's disease: Pathophysiology  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Spastic gait and mechanical energy recovery in children with hereditary spastic paraplegia

V. Maltese, S. Klebe, A. Marzegan, M. Dipaola, J. Volkmann, C.A. Frigo, P. Cavallari, I.U. Isaias (Wuerzburg, Germany)

Spasticity  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

SPAsticity in PractiCE (SPACE) – An international, observational study of botulinum toxin type A in spasticity

J. Wissel, J. Harriss, O. Simon, K. Sternberg, N. Roche, C. Cantú-Brito, S. Khatkova, P. Säterö (Berlin, Germany)

Spasticity  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Spatial accuracy and reliability of the Microsoft Kinect V2 in the assessment of joint movement in comparison to marker-based motion capture (Vicon)

K. Otte, B. Kayser, S. Mansow-Model, A.U. Brandt, J. Verrel, T. Schmitz-Hübsch (Berlin, Germany)

Technology  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Specificity and sensitivity of F-waves parameters in diagnosis of RLS/WED

P. Congiu, M.L. Fantini, G. Milioli, P. Tacconi, M. Figorilli, G. Gioi, B. Pereira, F. Marrosu, L. Parrino, M. Puligheddu (Monserrato, Italy)

Restless legs syndrome and other sleep disorders  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Speed and severity of toxicity induced by pre-formed α-synuclein fibrils in rat brain is enhanced by α-synuclein overexpression

P. Thakur, L. Breger, B. Mattsson, K. Luk, V.M. Lee, J. Trojanowski, A. Björklund (Lund, Sweden)

Parkinson's disease: Pathophysiology  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Stabilometry characteristics as objective Parkinson’s disease progression biomarkers

I.V. Miliukhina, T.V. Sergeev, E.V. Gracheva, A.V. Kudrevatykh, M.D. Didur (Saint-Petersburg, Russia)

Parkinson's disease: Pathophysiology  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Staging and clinical correlates of cortical thinning in Parkinson’s disease

H. Wilson, F. Niccolini, C. Pellicano, P. Piccini, M. Politis (London, United Kingdom)

Parkinson's disease: Pathophysiology  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Striatal PDE10 expression in Parkinson’s disease (PD) and healthy controls using [¹⁸F]MNI-659 PET imaging

D.S. Russell, D.L. Jennings, O. Barret, G.D. Tamagnan, D. Alagille, J.P. Seibyl, K.L. Marek (New Haven, CT, USA)

Parkinson's disease: Pathophysiology  ·  Exhibit Hall located in Hall B, Level 2